Ph.D., Chief Science Officer, Synthego
Rich Stoner is the Chief Scientific Officer at Synthego. Synthego’s mission is to turn biological research into an information science. At Synthego, Rich leads advanced research efforts in cell engineering, CRISPR bioinformatics, and therapeutic reagent design. Prior to Synthego, Rich founded a digital pathology startup (WholeSlide), combining whole slide virtual microscopy with cloud and mobile technologies. During that time, Rich consulted for leading research institutions (Memorial Sloan Kettering Cancer Center, MIT, IBM, and many others) to build state-of-the art tools for neuroanatomy visualization, medical education, and melanoma classification. Rich holds a PhD in Neural Engineering from the University of Pittsburgh. Before joining the startup world, he completed a postdoctoral fellowship at University of California, San Diego Neurosciences focused on neuroimaging- and gaze-based biomarker identification for the early diagnosis of autism spectrum disorders.
Emerging Therapeutics Showcase: Synthego
Synthego is a leading provider of genome engineering solutions, including software and synthetic RNA kits designed for CRISPR genome editing. With next-generation informatics and machine learning, Synthego’s vision is to enable precise, automated, rapid and cost-effective research for every scientist.
A Full-Stack Approach To Predictable Genome Engineering